Lakefront Biotherapeutics
LKFT
#5107
Rank
A$2.61 B
Marketcap
A$39.87
Share price
-1.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Lakefront Biotherapeutics (LKFT)

Earnings in 2026 (TTM): A$0.81 Billion

According to Lakefront Biotherapeutics's latest financial reports the company's current earnings are A$1.22 Billion. In 2025 the company made an earning of A$0.52 Billion, an increase over its 2024 earnings that were of -A$8.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lakefront Biotherapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.81 B55.04%
2025 A$0.52 B-6464.81%
2024 -A$8.28 Million-82.77%
2023 -A$48.04 Million-85.59%
2022 -A$0.34 Billion60.71%
2021 -A$0.21 Billion-60.08%
2020 -A$0.52 Billion-331.44%
2019 A$0.22 B-523.76%
2018 -A$52.99 Million-72.34%
2017 -A$0.2 Billion-329.59%
2016 A$83.44 M-144.3%
2015 -A$0.19 Billion